Kapolei
Kapolei
Kapolei, Hawaii, United States4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH) | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 3 | 2026-10-08 | NCT07575399 | |
| 'Ai Pono Cooking Demonstrations | Body Weight, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Recruiting | Not applicable | 2026-03-04 | NCT06526650 | |
| PILI 'Āina Household | Body Weight, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Recruiting | Not applicable | 2026-03-04 | NCT06526273 | |
| Household Participants | Body Weight, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Not yet recruiting | Not applicable | 2024-09-19 | NCT06590649 |